- Home
- RAPP vs BST Comparison
RAPP vs BST Comparison
Compare RAPP & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | RAPP | BST |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RAPP | BST |
|---|---|---|
| Price | $39.32 | $49.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.50 | N/A |
| AVG Volume (30 Days) | ★ 290.1K | 125.7K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.20 | $34.87 |
| 52 Week High | $42.27 | $49.19 |
Technical Indicators
Market Signals| Indicator | RAPP | BST |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 79.23 |
| Support Level | $25.48 | $38.63 |
| Resistance Level | $41.33 | N/A |
| Average True Range (ATR) | 2.08 | 1.04 |
| MACD | 0.18 | 0.32 |
| Stochastic Oscillator | 84.38 | 88.04 |
Price Performance
Historical ComparisonAbout RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objectives are to provide total return and income through long-term capital appreciation.